Neuro C

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

Ginkgo biloba, Quantity: 60 mg (Equivalent: Ginkgo biloba, Qty 3 g; Equivalent: Ginkgo flavonglycosides, Qty 14.7 mg; Equivalent: Ginkgolides and bilobalide, Qty 3.6 mg); d-alpha-tocopheryl acid succinate, Quantity: 8.26 mg; Bacopa monnieri, Quantity: 225 mg; soy phosphatidylserine-enriched soy lecithin powder, Quantity: 83.33 mg (Equivalent: soy phosphatidylserine, Qty 50 mg)

Available from:

Biomedica Nutraceuticals Pty Ltd

INN (International Name):

Bacopa monnieri,d-alpha-Tocopheryl acid succinate,Ginkgo biloba,soy phosphatidylserine-enriched soy lecithin powder

Pharmaceutical form:

Capsule, hard

Composition:

Excipient Ingredients: calcium hydrogen phosphate dihydrate; colloidal anhydrous silica; Rice bran; hypromellose; purified water; chlorophyllin-copper complex

Administration route:

Oral

Therapeutic indications:

Antioxidant/Reduce free radicals formed in the body ; Helps reduce/decrease free radical damage to body cells ; Maintain/support general health and wellbeing ; Maintain/support healthy blood circulation ; Maintain/support blood circulation/flow to the peripheral areas of the body (legs, hands and feet) ; Maintain/support cognitive function/mental function ; Maintain/support memory/mental recall ; Maintain/support brain health ; Maintain/support nervous system health

Product summary:

Visual Identification: ;

Authorization status:

Licence status A

Authorization date:

2017-07-25